Position in AMGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,053,033
+$35,920 QoQ
Shares Held
8,431
-1.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.58%
of 13F equity value
Holder Rank
#1,069
of 3,139 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WIMMER ASSOCIATES 1, LLC holds $14,096,189 across 8 Drug Manufacturers - General names. AMGN ranks #2 (21.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
12,574 | $3,164,121 | |
| 2 | AMGN |
Amgen Inc
This page
|
8,431 | $3,053,033 | |
| 3 | LLY |
ELI LILLY & Co
|
2,470 | $2,962,592 | |
| 4 | JNJ |
Johnson & Johnson
|
9,705 | $2,464,778 | |
| 5 | MRK |
Merck & Co., Inc.
|
10,952 | $1,407,332 | |
| 6 | NVS |
Novartis AG
|
2,594 | $406,531 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
3,110 | $392,917 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
4,250 | $244,885 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,053,033 | 8,431 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,017,113 | 8,575 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,757,259 | 8,424 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,389,387 | 8,467 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,383,615 | 8,537 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,645,994 | 8,493 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,280,600 | 8,750 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,943,388 | 9,135 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,862,042 | 9,160 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,604,371 | 9,160 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $2,633,942 | 9,145 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,460,497 | 9,155 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,970,871 | 8,877 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,146,014 | 8,877 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $2,421,015 | 9,218 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,049,787 | 9,094 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,187,023 | 8,989 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,134,545 | 8,827 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,005,832 | 8,916 | Shares | Sole | 2022-02-16 | |
| 2021-09-30 | $1,883,653 | 8,858 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,205,206 | 9,047 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $2,229,835 | 8,962 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,029,273 | 8,826 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,255,924 | 8,876 | Shares | Sole | 2020-12-03 | |
| 2020-06-30 | $2,012,121 | 8,531 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,807,135 | 8,914 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||